Building Trust in Multiomic Science: Why Quality and Regulatory Science Matter in Metabolomics
Multiomic research is reshaping how we understand biology. As datasets become more complex and interconnected, I’ve found that one thing matters more than ever: confidence in the data itself. Without that, even the most exciting discoveries can fall apart under scrutiny.
From my perspective as Senior Director of Quality Assurance and Regulatory Affairs, ensuring that multiomic and metabolomic data meet high standards of rigor and reproducibility isn’t just a technical requirement—it’s foundational. The pace of innovation is directly tied to how much we trust the data behind it.
How does regulatory science support the advancement of multiomic research?
Regulatory science is often associated with later stages of development, but its value begins much earlier. When regulatory science principles are incorporated into research workflows from the outset, they help establish clear frameworks for data quality, analytical validation, and reproducibility. These frameworks guide the generation, evaluation, and interpretation of complex datasets.
In multiomic research, regulatory science helps ensure discoveries are not only novel but also credible, reproducible, and capable of supporting future translational applications. Strong regulatory science also informs regulatory strategy, helping organizations position emerging technologies and datasets to ultimately support broader scientific and clinical innovation.
What makes metabolomics data unique from a regulatory or quality perspective?
Metabolomics occupies a distinctive place within the omics landscape. While genomics and proteomics capture biological potential, metabolomics reflects real-time biochemical activity within biological systems. That immediacy provides powerful insight—but it also introduces unique quality and regulatory considerations.
Metabolites are chemically diverse and highly dynamic, with concentrations that can shift in response to physiological conditions, environmental exposures, or even subtle differences in sample handling. Because of this sensitivity, metabolomic measurements are particularly influenced by pre-analytical variables, analytical performance, and data processing approaches.
From a regulatory science and quality perspective, ensuring reliability requires rigorous control across the entire workflow—from sample collection and preparation to analytical measurement and data interpretation. This includes demonstrating:
- Consistent analytical performance
- Well-controlled pre-analytical and analytical conditions
- Transparent data processing pipelines
- Reproducible measurements across studies and time
Without these safeguards, it becomes very difficult to build confidence in the data—especially as metabolomics is increasingly integrated into multiomic studies.
How do you ensure scientific robustness and rigor when working with complex, high-dimensional multiomic datasets?
Multiomic datasets are inherently high-dimensional, often involving thousands of variables across multiple biological layers. With that complexity comes variability and noise, and managing that is one of the biggest challenges.
In my experience, maintaining rigor comes down to discipline. Strong experimental design, standardized workflows, and clearly defined quality metrics aren’t optional — they’re essential. That includes everything from sample management to validated analytical methods to reproducible computational pipelines. Regulatory science and quality frameworks provide the structure needed to keep the science reliable and interpretable, even as the datasets scale.
Why is rigorous validation essential when integrating metabolomics into broader omics studies?
The promise of multiomics lies in integration—connecting insights across genomics, proteomics, metabolomics, and beyond.
But integration only works if each dataset is trustworthy.
Rigorous validation ensures that metabolomic measurements are accurate, reproducible, and biologically meaningful before they are incorporated into broader analyses. Without this foundation, combining datasets can amplify uncertainty rather than clarify biological relationships.
In many ways, the strength of multiomic insights ultimately depends on the quality and validation of the individual data layers contributing to the analysis.
How does cross-functional collaboration strengthen compliance and innovation?
At Metabolon, I’ve seen how critical cross-functional collaboration is. Bringing together R&D, Laboratory Operations, Bioinformatics, Regulatory & Quality, and Translational Science creates a much stronger foundation for innovation. When these groups work together early and consistently, quality and regulatory frameworks stop being seen as constraints and start acting as enablers. They help ensure that discoveries are not only exciting, but also credible, reproducible, and ready to support real-world applications.
Building trust in multiomic science takes more than advanced technology. It requires a shared commitment to rigor, transparency, and collaboration. In my view, innovation and credibility have to move forward together. Regulatory science and quality frameworks are what make that possible, ensuring that the insights we generate today will hold up to the scientific and translational challenges ahead.
